We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.
BERKELEY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two...
BERKELEY, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced an...
-- FDA has cleared Caribou’s IND application for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical trial expected to initiate by YE 2024 -- -- Driven by encouraging initial...
-- 30th patient dosed in CB-010 ANTLER Phase 1 trial dose expansion; initial dose expansion data and RP2D to be disclosed in Q2 2024 -- -- 1st patient dosed in CB-012 AMpLify Phase 1 trial for...
BERKELEY, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1 | -2.5641025641 | 3.9 | 4.21 | 3.69 | 1348203 | 3.87490789 | CS |
4 | -1.34 | -26.0700389105 | 5.14 | 5.15 | 3.69 | 1656288 | 4.27882157 | CS |
12 | -2.75 | -41.9847328244 | 6.55 | 8.33 | 3.69 | 1632052 | 5.63267291 | CS |
26 | -0.05 | -1.2987012987 | 3.85 | 8.33 | 3.44 | 1697946 | 5.43540569 | CS |
52 | -0.49 | -11.4219114219 | 4.29 | 8.5899 | 3.44 | 1949423 | 5.67362654 | CS |
156 | -13.85 | -78.4702549575 | 17.65 | 32.645 | 3.44 | 1117699 | 8.00819175 | CS |
260 | -13.85 | -78.4702549575 | 17.65 | 32.645 | 3.44 | 1117699 | 8.00819175 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions